{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:07:41Z","timestamp":1778220461277,"version":"3.51.4"},"reference-count":34,"publisher":"Journal of Biomedical Research","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2023]]},"DOI":"10.7555\/jbr.37.20230067","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T10:07:35Z","timestamp":1684836455000},"page":"340","source":"Crossref","is-referenced-by-count":6,"title":["Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity"],"prefix":"10.7555","volume":"37","author":[{"given":"Haozhe","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanxin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongping","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4380","reference":[{"key":"key-10.7555\/JBR.37.20230067-1","doi-asserted-by":"publisher","unstructured":"Lim IIP, Bondoc AJ, Geller JI, et al. Hepatoblastoma-the evolution of biology, surgery, and transplantation[J]. \n\t\t\t\t\t\t\t<i>Children<\/i>, 2018, 6(1): 1.","DOI":"10.3390\/children6010001"},{"key":"key-10.7555\/JBR.37.20230067-2","doi-asserted-by":"publisher","unstructured":"Kehm RD, Osypuk TL, Poynter JN, et al. Do pregnancy characteristics contribute to rising childhood cancer incidence rates in the United States?[J]. \n\t\t\t\t\t\t\t<i>Pediatr Blood Cancer<\/i>, 2018, 65(3): e26888.","DOI":"10.1002\/pbc.26888"},{"key":"key-10.7555\/JBR.37.20230067-3","doi-asserted-by":"publisher","unstructured":"Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma[J]. \n\t\t\t\t\t\t\t<i>Oncologist<\/i>, 2000, 5(6): 445\u2013453.","DOI":"10.1634\/theoncologist.5-6-445"},{"key":"key-10.7555\/JBR.37.20230067-4","doi-asserted-by":"publisher","unstructured":"Feng J, Polychronidis G, Heger U, et al. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study[J]. \n\t\t\t\t\t\t\t<i>Cancer Commun<\/i>, 2019, 39(1): 1\u20139.","DOI":"10.1186\/s40880-018-0346-4"},{"key":"key-10.7555\/JBR.37.20230067-5","doi-asserted-by":"publisher","unstructured":"Kremer N, Walther AE, Tiao GM. Management of hepatoblastoma: an update[J]. \n\t\t\t\t\t\t\t<i>Curr Opin Pediatr<\/i>, 2014, 26(3): 362\u2013369.","DOI":"10.1097\/MOP.0000000000000081"},{"key":"key-10.7555\/JBR.37.20230067-6","doi-asserted-by":"publisher","unstructured":"Warmann SW, Fuchs J. Drug resistance in hepatoblastoma[J]. \n\t\t\t\t\t\t\t<i>Curr Pharm Biotechnol<\/i>, 2007, 8(2): 93\u201397.","DOI":"10.2174\/138920107780487456"},{"key":"key-10.7555\/JBR.37.20230067-7","doi-asserted-by":"publisher","unstructured":"Arzumanian VA, Kiseleva OI, Poverennaya EV. The curious case of the HepG2 cell line: 40 years of expertise[J]. \n\t\t\t\t\t\t\t<i>Int J Mol Sci<\/i>, 2021, 22(23): 13135.","DOI":"10.3390\/ijms222313135"},{"key":"key-10.7555\/JBR.37.20230067-8","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Terrada D, Cheung SW, Finegold MJ, et al. Hep G2 is a hepatoblastoma-derived cell line[J]. \n\t\t\t\t\t\t\t<i>Hum Pathol<\/i>, 2009, 40(10): 1512\u20131515.","DOI":"10.1016\/j.humpath.2009.07.003"},{"key":"key-10.7555\/JBR.37.20230067-9","doi-asserted-by":"publisher","unstructured":"Clapham DE. Calcium signaling[J]. \n\t\t\t\t\t\t\t<i>Cell<\/i>, 2007, 131(6): 1047\u20131058.","DOI":"10.1016\/j.cell.2007.11.028"},{"key":"key-10.7555\/JBR.37.20230067-10","doi-asserted-by":"publisher","unstructured":"Yang Z, Yue Z, Ma X, et al. Calcium homeostasis: a potential vicious cycle of bone metastasis in breast cancers[J]. \n\t\t\t\t\t\t\t<i>Front Oncol<\/i>, 2020, 10: 293.","DOI":"10.3389\/fonc.2020.00293"},{"key":"key-10.7555\/JBR.37.20230067-11","doi-asserted-by":"publisher","unstructured":"Roderick HL, Cook SJ. Ca\n\t\t\t\t\t\t\t<sup>2+<\/sup> signalling checkpoints in cancer: remodelling Ca\n\t\t\t\t\t\t\t<sup>2+<\/sup> for cancer cell proliferation and survival[J]. \n\t\t\t\t\t\t\t<i>Nat Rev Cancer<\/i>, 2008, 8(5): 361\u2013375.","DOI":"10.1038\/nrc2374"},{"key":"key-10.7555\/JBR.37.20230067-12","doi-asserted-by":"publisher","unstructured":"Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors[J]. \n\t\t\t\t\t\t\t<i>Nat Rev Cancer<\/i>, 2011, 11(8): 609\u2013618.","DOI":"10.1038\/nrc3105"},{"key":"key-10.7555\/JBR.37.20230067-13","doi-asserted-by":"publisher","unstructured":"Liu Z, Wang L, Xu H, et al. Heterogeneous responses to mechanical force of prostate cancer cells inducing different metastasis patterns[J]. \n\t\t\t\t\t\t\t<i>Adv Sci<\/i>, 2020, 7(15): 1903583.","DOI":"10.1002\/advs.201903583"},{"key":"key-10.7555\/JBR.37.20230067-14","doi-asserted-by":"publisher","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, et al. The molecular signatures database hallmark gene set collection[J]. \n\t\t\t\t\t\t\t<i>Cell Syst<\/i>, 2015, 1(6): 417\u2013425.","DOI":"10.1016\/j.cels.2015.12.004"},{"key":"key-10.7555\/JBR.37.20230067-15","doi-asserted-by":"publisher","unstructured":"Yang N, Tang Y, Wang F, et al. Blockade of store-operated Ca\n\t\t\t\t\t\t\t<sup>2+<\/sup> entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover[J]. \n\t\t\t\t\t\t\t<i>Cancer Lett<\/i>, 2013, 330(2): 163\u2013169.","DOI":"10.1016\/j.canlet.2012.11.040"},{"key":"key-10.7555\/JBR.37.20230067-16","doi-asserted-by":"publisher","unstructured":"Easley IV CA, Brown CM, Horwitz AF, et al. CaMK-II promotes focal adhesion turnover and cell motility by inducing tyrosine dephosphorylation of FAK and paxillin[J]. \n\t\t\t\t\t\t\t<i>Cell Motil Cytoskeleton<\/i>, 2008, 65(8): 662\u2013674.","DOI":"10.1002\/cm.20294"},{"key":"key-10.7555\/JBR.37.20230067-17","doi-asserted-by":"publisher","unstructured":"Patergnani S, Danese A, Bouhamida E, et al. Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer[J]. \n\t\t\t\t\t\t\t<i>Int J Mol Sci<\/i>, 2020, 21(21): 8323.","DOI":"10.3390\/ijms21218323"},{"key":"key-10.7555\/JBR.37.20230067-18","doi-asserted-by":"publisher","unstructured":"Marchi S, Giorgi C, Galluzzi L, et al. Ca\n\t\t\t\t\t\t\t<sup>2+<\/sup> fluxes and cancer[J]. \n\t\t\t\t\t\t\t<i>Mol Cell<\/i>, 2020, 78(6): 1055\u20131069.","DOI":"10.1016\/j.molcel.2020.04.017"},{"key":"key-10.7555\/JBR.37.20230067-19","doi-asserted-by":"publisher","unstructured":"Roberts-Thomson SJ, Chalmers SB, Monteith GR. The calcium-signaling toolkit in cancer: remodeling and targeting[J]. \n\t\t\t\t\t\t\t<i>Cold Spring Harb Perspect Biol<\/i>, 2019, 11(8): a035204.","DOI":"10.1101\/cshperspect.a035204"},{"key":"key-10.7555\/JBR.37.20230067-20","doi-asserted-by":"publisher","unstructured":"Wu L, Lian W, Zhao L. Calcium signaling in cancer progression and therapy[J]. \n\t\t\t\t\t\t\t<i>FEBS J<\/i>, 2021, 288(21): 6187\u20136205.","DOI":"10.1111\/febs.16133"},{"key":"key-10.7555\/JBR.37.20230067-21","doi-asserted-by":"publisher","unstructured":"Koivisto AP, Belvisi MG, Gaudet R, et al. Advances in TRP channel drug discovery: from target validation to clinical studies[J]. \n\t\t\t\t\t\t\t<i>Nat Rev Drug Discov<\/i>, 2022, 21(1): 41\u201359.","DOI":"10.1038\/s41573-021-00268-4"},{"key":"key-10.7555\/JBR.37.20230067-22","doi-asserted-by":"publisher","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. \n\t\t\t\t\t\t\t<i>Cell<\/i>, 2011, 144(5): 646\u2013674.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"key-10.7555\/JBR.37.20230067-23","doi-asserted-by":"publisher","unstructured":"Monteith GR, Prevarskaya N, Roberts-Thomson SJ. The calcium-cancer signalling nexus[J]. \n\t\t\t\t\t\t\t<i>Nat Rev Cancer<\/i>, 2017, 17(6): 373\u2013380.","DOI":"10.1038\/nrc.2017.18"},{"key":"key-10.7555\/JBR.37.20230067-24","doi-asserted-by":"publisher","unstructured":"Gupta SC, Singh R, Asters M, et al. Regulation of breast tumorigenesis through acid sensors[J]. \n\t\t\t\t\t\t\t<i>Oncogene<\/i>, 2016, 35(31): 4102\u20134111.","DOI":"10.1038\/onc.2015.477"},{"key":"key-10.7555\/JBR.37.20230067-25","doi-asserted-by":"publisher","unstructured":"Joeckel E, Haber T, Prawitt D, et al. High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor[J]. \n\t\t\t\t\t\t\t<i>Mol Cancer<\/i>, 2014, 13: 42.","DOI":"10.1186\/1476-4598-13-42"},{"key":"key-10.7555\/JBR.37.20230067-26","doi-asserted-by":"publisher","unstructured":"Zhivotovsky B, Orrenius S. Calcium and cell death mechanisms: a perspective from the cell death community[J]. \n\t\t\t\t\t\t\t<i>Cell Calcium<\/i>, 2011, 50(3): 211\u2013221.","DOI":"10.1016\/j.ceca.2011.03.003"},{"key":"key-10.7555\/JBR.37.20230067-27","doi-asserted-by":"publisher","unstructured":"Sukumaran P, Da Conceicao VN, Sun Y, et al. Calcium signaling regulates autophagy and apoptosis[J]. \n\t\t\t\t\t\t\t<i>Cells<\/i>, 2021, 10(8): 2125.","DOI":"10.3390\/cells10082125"},{"key":"key-10.7555\/JBR.37.20230067-28","doi-asserted-by":"publisher","unstructured":"Ding LS, Sun XY, You YP, et al. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival[J]. \n\t\t\t\t\t\t\t<i>Transl Res<\/i>, 2010, 156(1): 45\u201352.","DOI":"10.1016\/j.trsl.2010.05.001"},{"key":"key-10.7555\/JBR.37.20230067-29","doi-asserted-by":"publisher","unstructured":"Teutschbein J, Schartl M, Meierjohann S. Interaction of \n\t\t\t\t\t\t\t<i>Xiphophorus<\/i> and murine Fyn with focal adhesion kinase[J]. \n\t\t\t\t\t\t\t<i>Comp Biochem Physiol C Toxicol Pharmacol<\/i>, 2009, 149(2): 168\u2013174.","DOI":"10.1016\/j.cbpc.2008.09.013"},{"key":"key-10.7555\/JBR.37.20230067-30","doi-asserted-by":"publisher","unstructured":"Peng JM, Tseng RH, Shih TC, et al. CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling[J]. \n\t\t\t\t\t\t\t<i>Cancer Lett<\/i>, 2021, 497: 66\u201376.","DOI":"10.1016\/j.canlet.2020.10.017"},{"key":"key-10.7555\/JBR.37.20230067-31","doi-asserted-by":"publisher","unstructured":"Chen W, An P, Quan X, et al. Ca\n\t\t\t\t\t\t\t<sup>2+<\/sup>\/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1\/2 and p38 pathways[J]. \n\t\t\t\t\t\t\t<i>World J Gastroenterol<\/i>, 2017, 23(33): 6111\u20136118.","DOI":"10.3748\/wjg.v23.i33.6111"},{"key":"key-10.7555\/JBR.37.20230067-32","doi-asserted-by":"publisher","unstructured":"Lu KK, Armstrong SE, Ginnan R, et al. Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle[J]. \n\t\t\t\t\t\t\t<i>Am J Physiol Cell Physiol<\/i>, 2005, 289(5): C1343\u2013C1350.","DOI":"10.1152\/ajpcell.00064.2005"},{"key":"key-10.7555\/JBR.37.20230067-33","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu Y, Liu Y, et al. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma[J]. \n\t\t\t\t\t\t\t<i>Int J Pharm<\/i>, 2015, 483(1\u20132): 89\u2013100.","DOI":"10.1016\/j.ijpharm.2015.02.027"},{"key":"key-10.7555\/JBR.37.20230067-34","doi-asserted-by":"publisher","unstructured":"Huang C, Chen JYF, Wu J, et al. Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells[J]. \n\t\t\t\t\t\t\t<i>J Agric Food Chem<\/i>, 2010, 58(15): 8798\u20138805.","DOI":"10.1021\/jf1020158"}],"container-title":["The Journal of Biomedical Research"],"original-title":[],"link":[{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.37.20230067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:04:25Z","timestamp":1695866665000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.37.20230067?viewType=HTML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"alternative-id":["JBR-2023-0067"],"URL":"https:\/\/doi.org\/10.7555\/jbr.37.20230067","relation":{},"ISSN":["1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}